IGALMI

Welcome to the Brand page for “IGALMI”, which is offered here for Pharmaceuticals for the treatment of agitation, an orally-dissolving formulation used for the treatment of agitation associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders, schizophrenia, bipolar disorder, dementia, and depression;.

Its status is currently believed to be active. Its class is unavailable. “IGALMI” is believed to be currently owned by “Bioxcel Therapeutics, Inc.”

Owner:
BIOXCEL THERAPEUTICS, INC.
Owner Details
Description:
Pharmaceuticals for the treatment of agitation, an orally-dissolving formulation used for the treatment of agitation associated with alcohol withdrawal, opioid use disorder, opioid withdrawal, substance abuse withdrawal, or other central nervous system disorders, schizophrenia, bipolar disorder, dementia, and depression;
Categories: PHARMACEUTICALS TREATMENT